• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman.

作者信息

Elfering Lian, van der Sluis Wouter B, Mermans Joline F, Buncamper Marlon E

机构信息

1 Department of Plastic, Reconstructive and Hand Surgery, VU University Medical Center, Amsterdam, the Netherlands.

2 Center of Expertise on Gender Dysphoria, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Int J STD AIDS. 2017 Jul;28(8):841-843. doi: 10.1177/0956462416685658. Epub 2016 Dec 19.

DOI:10.1177/0956462416685658
PMID:28632111
Abstract

A 24-year-old transgender woman consulted our outpatient clinic with a painful, itchy and red left labia. She underwent a penile inversion vaginoplasty 18 months before presentation. At physical examination of the left labia, erythema, edema and herpetic vesicles with ulceration were observed. A vesicle fluid swab was obtained and the presence of herpes simplex virus type 1 (HSV-1) was detected by PCR assay. Treatment consisted of oral valaciclovir (500 mg twice daily) for a total of five days.Topically-applied lidocaine cream (3%) was used for pain management. Treatment gave symptom relief in five days. At physical examination 14 days after symptom onset, there were no signs of active infection. To our knowledge, this is the first case report of HSV-1 infection of the neolabia in a transgender woman.

摘要

相似文献

1
Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman.
Int J STD AIDS. 2017 Jul;28(8):841-843. doi: 10.1177/0956462416685658. Epub 2016 Dec 19.
2
ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.美国妇产科医师学会实践公告:妇产科临床管理指南,第57号,2004年11月。妇科单纯疱疹病毒感染
Obstet Gynecol. 2004 Nov;104(5 Pt 1):1111-8.
3
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.口服伐昔洛韦用于复发性生殖器疱疹发作期治疗的大规模、安慰剂对照、剂量范围试验。伐昔洛韦单纯疱疹病毒研究组。
Arch Intern Med. 1996;156(15):1729-35.
4
Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.伐昔洛韦用于单纯疱疹病毒感染:在使用阿昔洛韦20年经验后的长期安全性和持续疗效。
J Infect Dis. 2002 Oct 15;186 Suppl 1:S40-6. doi: 10.1086/342966.
5
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.伐昔洛韦与阿昔洛韦治疗HIV感染个体单纯疱疹病毒感染的两项随机试验。
Int J STD AIDS. 2002 Jan;13(1):12-21. doi: 10.1258/0956462021924550.
6
The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.每日服用伐昔洛韦抑制对无生殖器疱疹病史的单纯疱疹病毒2型血清阳性受试者单纯疱疹病毒2型病毒排出的影响。
Sex Transm Dis. 2008 Mar;35(3):286-90. doi: 10.1097/OLQ.0b013e31815b0132.
7
Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.伐昔洛韦与阿昔洛韦治疗原发性生殖器单纯疱疹的成本分析。
Int J STD AIDS. 2015 Nov;26(13):971-3. doi: 10.1177/0956462414563628. Epub 2014 Dec 12.
8
An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.一项关于伐昔洛韦用于抑制新诊断患者单纯疱疹病毒2型生殖器疱疹的国际、随机、双盲、安慰剂对照研究。
Sex Transm Dis. 2008 Jul;35(7):668-73. doi: 10.1097/OLQ.0b013e31816d1f42.
9
One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.伐昔洛韦一日疗法治疗复发性2型单纯疱疹病毒生殖器感染
Sex Transm Dis. 2008 Apr;35(4):383-6. doi: 10.1097/OLQ.0b013e31815e4190.
10
Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.伐昔洛韦用于早期生殖器疱疹的抑制疗法:临床疗效及疱疹相关生活质量的初步研究
Sex Transm Dis. 2007 Jun;34(6):339-43. doi: 10.1097/01.olq.0000243620.13718.56.

引用本文的文献

1
Infections Following Gender-Affirming Vaginoplasty: A Single-Center Experience.性别确认阴道成形术后感染:单中心经验
Open Forum Infect Dis. 2024 Sep 11;11(10):ofae526. doi: 10.1093/ofid/ofae526. eCollection 2024 Oct.
2
Anatomical and sexual health considerations among transfeminine individuals who have undergone vaginoplasty: A review.跨性别女性行阴道成形术后的解剖学和性健康考虑因素:综述。
Int J STD AIDS. 2022 Feb;33(2):106-113. doi: 10.1177/09564624211046997. Epub 2021 Oct 6.
3
Sexually Transmitted Infections Treatment Guidelines, 2021.
《2021年性传播感染治疗指南》
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
4
Infection of the Neovagina in Transgender Women.transgender女性新阴道的感染
Open Forum Infect Dis. 2019 Nov 11;6(11):ofz470. doi: 10.1093/ofid/ofz470. eCollection 2019 Nov.
5
PATTERN OF PRESENTATION OF ORAL ULCERATIONS IN PATIENTS ATTENDING AN ORAL MEDICINE CLINIC IN NIGERIA.尼日利亚口腔医学门诊患者口腔溃疡的表现模式
Ann Ib Postgrad Med. 2018 Jun;16(1):9-11.